Muhammad Hamid Siddique

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Inflammatory Response

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Muhammad Hamid Siddique, Sidra Bukhari, Inam Ullah Khan, Asiya Essa, Zain Ali, Usama Sabir, Omiya Ayoub, Haleema Saadia, Muhammad Yaseen, Aneesa Sultan, Iram Murtaza, Philip G Kerr, Mashooq Ahmad Bhat, Mariam Anees
In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Muhammad Hamid Siddique, Sidra Bukhari, Inam Ullah Khan, Asiya Essa, Zain Ali, Usama Sabir, Omiya Ayoub, Haleema Saadia, Muhammad Yaseen, Aneesa Sultan, Iram Murtaza, Philip G Kerr, Mashooq Ahmad Bhat, Mariam Anees
In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Sidra Bukhari, Muhammad Hamid Siddique, Anum Naeem, InamUllah Khan, Zain Ali, Asiya Essa, Falak Fazal, Riffat Aysha Anis, Lukas Moran, Aneesa Sultan, Iram Murtaza, Petr Vanhara, Mariam Anees
Combined efficacy of Cinnamomum zeylanicum and doxorubicin against leukemia through regulation of TRAIL and NF-kappa B pathways in rat model. Molecular biology reports 49 (7) (2022)